Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Large sample tests for binary outcomes in fixed-dose combination drug studies

S J Wang1, H M Hung

  • 1Division of Biometrics I, Food and Drug Administration, Rockville, Maryland 20852, USA.

Biometrics
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug profiling: a new scientific contribution to law enforcement operations in Viet Nam.

Bulletin on narcotics·2011
Same author

Microscopic polyangiitis presenting with capsular warning syndrome and subsequent stroke.

Journal of the neurological sciences·2008
Same author

Intranasal delivery of T-bet modulates the profile of helper T cell immune responses in experimental asthma.

Journal of investigational allergology & clinical immunology·2008
Same author

Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and beta2-adrenoceptor mechanisms.

British journal of pharmacology·2008
Same author

X-ray lasers from Inner-shell transitions pumped by the Free-electron laser.

Optics express·2008
Same author

Effective fast electron acceleration along the target surface.

Optics express·2008
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

This study introduces new statistical tests to evaluate combination drug therapy effectiveness compared to single drugs. The developed methods accurately assess power and error rates, even with unequal sample sizes, aiding clinical trial design.

Area of Science:

  • Biostatistics
  • Pharmacology
  • Clinical Trial Design

Background:

  • Combination drug therapy is increasingly used, necessitating robust statistical methods to evaluate its efficacy.
  • Fixed-dose combination regimens require comparison against individual drug treatments.

Purpose of the Study:

  • To develop and evaluate statistical tests for comparing combination drug therapy against single-drug treatments for dichotomous outcomes.
  • To assess the performance of these tests regarding power and Type I error rates under various conditions.

Main Methods:

  • Development of several test statistics for comparing combination therapy to monotherapy.
  • Derivation of large-sample power functions and significance levels.
  • Evaluation of test performance with varying sample sizes and response probabilities.

Related Experiment Videos

Main Results:

  • Developed tests accurately estimate power and Type I error rates for sample sizes of 20 or more (response probability 0.2-0.8).
  • Tests exhibit similar power behaviors in large samples.
  • Small sample sizes can lead to under- or overestimation of Type I error rates with specific tests.
  • Unequal sample sizes generally result in a minor loss of statistical power.

Conclusions:

  • The developed statistical tests are valuable for assessing the efficacy of fixed-dose combination drug regimens.
  • The methods provide reliable power and error rate calculations for clinical trials with adequate sample sizes.
  • Consideration of small sample limitations and unbalanced group sizes is crucial for accurate interpretation.